Imaging and Circulating Biomarker-Defined Cardiac Pathology in Pulmonary Tuberculosis: A Systematic Review
References
- World Health Organization. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: Background Document [Internet]. World Health Organization; 2021 [cited 2022 May 16]. Available from:
https://apps.who.int/iris/handle/10665/341980 . - World Health Organization. Non communicable diseases [Internet]. World Health Organization; 2023 [cited 2023 March 15. Available from:
https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases . - Mocumbi AO. Cardiovascular health care in low- and middle-income countries. Circulation. 2024; 149(8):557–559. DOI: 10.1161/CIRCULATIONAHA.123.065717
- Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: Worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018; 392(10152):1072–1088. DOI: 10.1016/S0140-6736(18)31992-5
- Farina JM, Liblik K, Iomini P, Miranda-Arboleda AF, Saldarriaga C, Mendoza I, et al. Infections and cardiovascular disease: JACC focus seminar 1/4. J Am Coll Cardiol. 2023; 81(1):71–80. DOI: 10.1016/j.jacc.2022.08.813
- World Health Organization. Global tuberculosis report 2023 [Internet]. 1st ed. World Health Organization; 2023. [cited 2024 October 12]. Available from:
https://iris.who.int/bitstream/handle/10665/373828/9789240083851-eng.pdf?sequence=1 . - Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primer. 2016; 2(1):1–23. DOI: 10.1038/nrdp.2016.76
- López-López JP, Posada-Martínez EL, Saldarriaga C, Wyss F, Ponte-Negretti CI, Alexander B, et al. Tuberculosis and the heart. J Am Heart Assoc. 2021; 10(7):
e019435 . DOI: 10.1161/JAHA.120.019435 - Marcu DTM, Adam CA, Mitu F, Cumpat C, Onofrei VA, Zabara ML, et al. Cardiovascular involvement in tuberculosis: from pathophysiology to diagnosis and complications—A narrative review. Diagnostics. 2023; 13(3). DOI: 10.3390/diagnostics13030432
- van Heerden JK, Louw EH, Thienemann F, Engel ME, Allwood BW. The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis. Eur Respir Rev. 2024; 33(171):230154. DOI: 10.1183/16000617.0154-2023
- Allwood BW, Manie S, Stolbrink M, Hunter L, Mathee S, Meintjes G, et al. Pulmonary hypertension in adults completing tuberculosis treatment. Afr J Thorac Crit Care Med. 2023; 29(3). DOI: 10.7196/AJTCCM.2023.v29i3.676
- Louw E, Baines N, Maarman G, Osman M, Sigwadhi L, Irusen E, et al. The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients. Pulm Circ. 2023; 13(1):
e12184 . DOI: 10.1002/pul2.12184 - Basham CA, Smith SJ, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PloS One. 2020; 15(7):
e0235821 . DOI: 10.1371/journal.pone.0235821 - Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: A prospective descriptive autopsy study. Lancet Infect Dis. 2015; 15(5):544–551. DOI: 10.1016/S1473-3099(15)70058-7
- Mucheleng’anga LA, Himwaze CM, Telendiy V, Simumba S, Soko J, Kayonde N, et al. Incidental Tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia – A descriptive forensic post-mortem examination study. Int J Infect Dis. 2022; 124:S75–S81. DOI: 10.1016/j.ijid.2022.03.005
- Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018; 392(10151):919–928. DOI: 10.1016/S0140-6736(18)31923-8
- Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Exp Med. 2003; 26(3):133–147.
- Welsh P, Campbell RT, Mooney L, Kimenai DM, Hayward C, Campbell A, et al. Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort. Circ Heart Fail. 2022; 15(10):
e009427 . DOI: 10.1161/CIRCHEARTFAILURE.121.009427 - National Heart, Lung, and Blood Institute. Study Quality Assessment Tools [Internet]. NIH [updatd 2021 July; cited 2023 March 21]. Available from:
https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools . - Casas E, Blanco JR, Ibarra V, Metola L, Rosel L, Oteo JA. Incidence of pericardial effusion in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000; 4(12):1173–1175.
- Patel MN, Beningfield S, Burch V. Abdominal and pericardial ultrasound in suspected extrapulmonary or disseminated tuberculosis. South Afr Med J. 2011; 101(1):39–42. DOI: 10.7196/SAMJ.4201
- Kahn D, Pool KL, Phiri L, Chibwana F, Schwab K, Longwe L, et al. Diagnostic utility and impact on clinical decision making of focused assessment with sonography for hiv-associated tuberculosis in Malawi: A prospective cohort study. Glob Health Sci Pract. 2020; 8(1):28–37. DOI: 10.9745/GHSP-D-19-00251
- Patil SV, Toshniwal S, Acharya A, Gondhali G. Cardiac dysfunction in active pulmonary tuberculosis: Mysterious facts of TB’s pandora. Electron J Gen Med. 2023; 20(2):
em452 . DOI: 10.29333/ejgm/12834 - Ankrah A, Lawal I, Glaudemans A, Slart R, Sathekge M. Intense uniform FDG myocardial uptake during anti-tuberculous therapy. J Nucl Med. 2019; 60(supplement 1):1064.
- Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, et al. PET/CT features of extrapulmonary tuberculosis at first clinical presentation: A cross-sectional observational 18F-FDG imaging study across six countries. Eur Respir J. 2020; 55(2):1901959. DOI: 10.1183/13993003.01959-2019
- Mukasa S, Aremu O, Wolmarans K, Mashinyira A, Katoto P, Jakoet-Bassier F, et al. Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment – preliminary findings of participants co-enrolled into the StatinTB trial and cardiac imaging after TB (CIA-TB) study. Eur Heart J. 2022; 43(Supplement_2):
ehac544.2607 . DOI: 10.1093/eurheartj/ehac544.2607 - Lazarou E, Tsioufis P, Vlachopoulos C, Tsioufis C, Lazaros G. Acute Pericarditis: Update. Curr Cardiol Rep. 2022; 24(8):905–913. DOI: 10.1007/s11886-022-01710-8
- Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008; 94(4):498–501. DOI: 10.1136/hrt.2006.104067
- Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011; 124(11):1270–1275. DOI: 10.1161/CIRCULATIONAHA.111.018580
- Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021; 18(6):424–434. DOI: 10.1038/s41569-020-00492-2
- L’Heureux M, Sternberg M, Brath L, Turlington J, Kashiouris MG. Sepsis-Induced Cardiomyopathy: A comprehensive review. Curr Cardiol Rep. 2020; 22(5):35. DOI: 10.1007/s11886-020-01277-2
- Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, et al. Comparison of BNP and NT-proBNP in Patients with heart failure and reduced ejection fraction. Circ Heart Fail. 2020; 13(2):
e006541 . DOI: 10.1161/CIRCHEARTFAILURE.119.006541 - Hudson JA, Majonga ED, Ferrand RA, Perel P, Alam SR, Shah ASV. Association of HIV infection with cardiovascular pathology based on advanced cardiovascular imaging: a systematic review. JAMA. 2022; 328(10):951–962. DOI: 10.1001/jama.2022.15078
- Ahmed HA, Mohamed J, Akuku IG, Lee KK, Alam SR, Perel P, et al. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: A pilot cross-sectional study. BMJ Open. 2022; 12(6):
e062352 . DOI: 10.1136/bmjopen-2022-062352 - Olalla J, Crespo E, De la Torre J, Sempere M, Del Arco A, Prada JL, et al. Factors related to NT-proBNP levels in HIV patients aged over 40 years. AIDS Res Ther. 2015; 12(101237921):17. DOI: 10.1186/s12981-015-0058-7
- Peterson TE, Baker JV, Wong LY, Rupert A, Ntusi NAB, Esmail H, et al. Elevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban township. ESC Heart Fail. 2020; 7(5):3246–3251. DOI: 10.1002/ehf2.12849
- Robbertse PPS, Doubell AF, Steyn J, Lombard CJ, Talle MA, Herbst PG. Altered cardiac structure and function in newly diagnosed people living with HIV: A prospective cardiovascular magnetic resonance study after the initiation of antiretroviral treatment. Int J Cardiovasc Imaging. 2023; 39(1):169–182. DOI: 10.1007/s10554-022-02711-y
- Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet. 1990; 335(8683):209–212. DOI: 10.1016/0140-6736(90)90288-G
- Maher D, Harries AD. Tuberculous pericardial effusion: A prospective clinical study in a low-resource setting—Blantyre, Malawi. Int J Tuberc Lung Dis. 1997; 1(4):358–364.
- Reuter H, Burgess LJ, Doubell AF. Epidemiology of Pericardial Effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005; 133(3):393–399. DOI: 10.1017/S0950268804003577
- Ntsekhe M, Hakim J. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation. 2005; 112(23):3602–3607. DOI: 10.1161/CIRCULATIONAHA.105.549220
- Scopazzini MS, Chansa P, Majonga ED, Bual N, Schaap A, Mateyo KJ, et al. The burden and natural history of cardiac pathology at TB diagnosis in a high-HIV prevalence district in Zambia: protocol for the TB-Heart study. BMC Cardiovasc Disord. 2024; 24(1):205. DOI: 10.1186/s12872-024-03877-0
- Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013; 18(3):367–373. DOI: 10.1007/s10741-012-9310-6
- Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa: original article. S Afr Med J. 2008; 98(1):36–40. DOI: 10.10520/EJC69118
- Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the management of pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006; 6(1):2. DOI: 10.1186/1471-2334-6-2
- Michira BN, Alkizim FO, Matheka DM. Patterns and clinical manifestations of tuberculous myocarditis: A systematic review of cases. Pan Afr Med J. 2015; 21(118). DOI: 10.11604/pamj.2015.21.118.4282
- Mohan A, Thachil A, Sundar G, Sastry BKS, Hasan A, Sridevi C, et al. Ventricular tachycardia and tuberculous lymphadenopathy: Sign of myocardial tuberculosis? J Am Coll Cardiol. 2015; 65(2):218–220. DOI: 10.1016/j.jacc.2014.09.087
DOI: https://doi.org/10.5334/gh.1369 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jun 2, 2024
Accepted on: Oct 23, 2024
Published on: Nov 8, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2024 Marcello S. Scopazzini, Katherine J. Hill, Edith D. Majonga, Dominik Zenner, Helen Ayles, Anoop S. V. Shah, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.